A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics

Amy E. Campbell, Jamshid Arjomand, Oliver D. King, Rabi Tawil, Sujatha Jagannathan
doi: https://doi.org/10.1101/2022.07.25.22276982

Article usage

Article usage: July 2022 to December 2024

AbstractFullPdf
Jul 2022329832
Aug 20221341344
Sep 2022702112
Oct 2022612117
Nov 2022701715
Dec 2022301413
Jan 2023201111
Feb 2023251413
Mar 20232211636
Apr 2023703311
May 2023382912
Jun 2023202013
Jul 2023191010
Aug 2023302015
Sep 2023221410
Oct 2023361616
Nov 202332910
Dec 20231141
Jan 2024211211
Feb 202418139
Mar 202414157
Apr 2024111015
May 2024261215
Jun 202417913
Jul 202471414
Aug 202413516
Sep 202437610
Oct 20241788
Nov 202412314
Dec 2024163
Back to top
Posted March 13, 2023.
Download PDF

Supplementary Material

Data/Code
Email
A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics
Amy E. Campbell, Jamshid Arjomand, Oliver D. King, Rabi Tawil, Sujatha Jagannathan
medRxiv 2022.07.25.22276982; doi: https://doi.org/10.1101/2022.07.25.22276982
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area